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The high-resolution structure of the NADP(H)-binding
component (dIII) of proton-translocating transhydrogenase from
human heart mitochondria
Scott A White1* Sarah J Peake1, Sean McSweeney2, Gordon Leonard3,
Nick PJ Cotton1 and J Baz Jackson1*
Background: Transhydrogenase, located in the inner membranes of animal
mitochondria and the cytoplasmic membranes of bacteria, couples the transfer
of reducing equivalents between NAD(H) and NADP(H) to proton pumping. The
protein comprises three subunits termed dI, dII and dIII. The dII component
spans the membrane. The dI component, which contains the binding site for
NAD+/NADH, and the dIII component, which has the binding site for
NADP+/NADPH, protrude from the membrane. Proton pumping is probably
coupled to changes in the binding affinities of dIII for NADP+ and NADPH.
Results: The first X-ray structure of the NADP(H)-binding component, dIII, of
human heart transhydrogenase is described here at 2.0 Å resolution. It
comprises a single domain resembling the classical Rossmann fold, but NADP+
binds to dIII with a reversed orientation. The first βαβαβ motif of dIII contains a
Gly-X-Gly-X-X-Ala/Val ‘fingerprint’, but it has a different function to that in the
classical Rossmann structure. The nicotinamide ring of NADP+ is located on a
ridge where it is exposed to interaction with NADH on the dI subunit. Two
distinctive features of the dIII structure are helix D/loop D, which projects from
the β sheet, and loop E, which forms a ‘lid’ over the bound NADP+.
Conclusions: Helix D/loop D interacts with the bound nucleotide and loop E,
and probably interacts with the membrane-spanning dII. Changes in ionisation
and conformation in helix D/loop D, resulting from proton translocation through
dII, are thought to be responsible for the changes in affinity of dIII for NADP+
and NADPH that drive the reaction.
Introduction
The living cell maintains its pools of NAD(H) and
NADP(H) at different redox potentials to allow indepen-
dent control of catabolism and biosynthesis. NAD+ is the
predominant soluble electron acceptor in catabolism and
under aerobic conditions its reduced form, NADH, can
subsequently provide electrons to the respiratory chain.
On the other hand, the major supplier of reducing power
in biosynthesis is NADPH. Transhydrogenase, which
catalyses the transfer of reducing equivalents between
NAD(H) and NADP(H), occupies the interface between
the two nicotinamide nucleotide pools, but not in an unre-
stricted way. Its chemical reaction is coupled to the
translocation of H+ across a cell membrane.
(1)
Located in the inner mitochondrial membrane of animal
cells and the cytoplasmic membrane of bacterial cells,
transhydrogenase is driven to the right (Equation 1) by the
proton electrochemical gradient (∆p) that results from the
action of the respiratory chain or, in some organisms, the
photosynthetic electron transport chain. In bacteria, this
action of transhydrogenase is thought to be partly respon-
sible for the provision of reducing power for amino acid
biosynthesis and detoxification [1]. In animal mitochon-
dria, similar pathways might operate but the situation is
more complex [2]. Here, it is probable that the main func-
tion of transhydrogenase, acting in combination with the
NAD- and NADP-linked isocitrate dehydrogenases, is to
control flux through the tricarboxylic acid cycle [3].
Transhydrogenase is often described as a proton pump
because, operating in the reverse direction (see
Equation 1), the enzyme generates rather than consumes
∆p. One H+ is translocated across the membrane for each
hydride equivalent transferred between nucleotides (χ = 1
in Equation 1 [4]). As an ion pump, however, transhydro-
genase is unusual in that the difference between the stan-
dard Gibbs free energy of the nucleotide reactants and
products is close to zero; the energy used to generate ∆p is
++++ χ++⇔χ++ INOUT HNADPHNADHNADPNADH
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solely derived from the concentration terms of reactants
and products in the same aqueous phase. As with many
other biological ion pumps, an understanding of the mech-
anism by which the scalar chemistry (of transhydrogena-
tion in this case) is coupled to vectorial proton
translocation is limited by the lack of information on the
protein structure.
Transhydrogenase has a tripartite arrangement of sub-
units. The dII component spans the membrane and the dI
and dIII components protrude from the membrane (on
the matrix side in mitochondria). The binding site for
NAD+ and NADH is located on dI, and that for NADP+
and NADPH is located on dIII. Recombinant forms of dI
and dIII from transhydrogenases of a number of species
have been prepared and found to bind their cognate
nucleotides (see [5] for references). Simple mixtures of
the dI and dIII proteins catalyse transhydrogenation but at
a very low rate. Although the hydride transfer step, at least
in some recombinant dI–dIII complexes, is fast [6,7], the
overall steady-state rate of reaction is limited by very slow
release of product NADPH (in the forward direction) and
NADP+ (in the reverse direction) [8]. It was proposed that
the slow release of nucleotides from isolated dIII and from
dI–dIII complexes results from the absence of interaction
with dII. This is consistent with a ‘binding-change’ mech-
anism of energy coupling in transhydrogenase (so-called
because of an analogy with that described for the
F0F1-ATPase [9]). In our version of this mechanism, pro-
tonation and deprotonation of dII (or dII–dIII), on oppo-
site sides of the membrane, lead to conformational
changes in dIII, which promote a switch in the NADP+-
and NADPH-binding affinities and thus drive the reaction
to the right in Equation 1 [10,11]. NADH is effectively a
passive donor of reducing equivalents [12,13]. Other ver-
sions of the binding-change mechanism have been out-
lined, in which events at both the NAD(H) and NADP(H)
sites are coupled to H+ translocation [14,15].
In this report, we describe the high-resolution crystal
structure of the recombinant dIII component of human
transhydrogenase in its NADP+-bound form. Structural
features indicate how it might interact with dI and dII,
and provide an insight as to how changes in the binding
affinity of dIII for NADP+ and NADPH might be coupled
to proton translocation.
Results and discussion
The protein fold
The dIII component of human transhydrogenase (Figure 1)
folds into a single, compact domain ~34 × 35 × 50 Å. The
overall fold (Figure 2a) resembles the dinucleotide-binding
fold, or Rossmann fold, found in many soluble dehydroge-
nases [16]. Thus, the protein comprises an open, twisted β
sheet of six parallel strands (β1 to β6), flanked by helices (0
and A to F). As in the classical lactate dehydrogenase
(LDH) structure, two βαβαβ motifs can be distinguished.
The N-terminal strands of each of the two motifs lie in the
centre of the sheet. The associated helices in the first
motif are folded on the opposite side of the sheet to those
in the second motif, giving rise to a line of pseudo-symme-
try between the two units. A ‘cross-over’ helix, helix C,
which has a predominantly 310 character, links the C ter-
minus of strand β3 with the N terminus of strand β4. One
extra α helix, helix 0, preceding strand β1, passes down
the ‘back’ of the molecule and packs against the N-termi-
nal ends of strands β6, β5, β4 and β1. Another helix, helix
F, at the C terminus of β6, also runs down the back and
packs between helix 0 and helix A. The first two helices in
the second βαβαβ unit are considerably distorted. The
segment designated helix D/loop D is a very distinctive
feature. The polypeptide chain turns from the carboxyl
end of β4, at the invariant Gly964, and with a single turn
of 310 helix followed by a single turn of α helix it protrudes
at the front of the molecule, almost perpendicular to the
sheet, before terminating in three consecutive β turns
between Asp976 and Met984. The polypeptide chain then
passes back, towards the β sheet, to be followed by a short
segment of 310 helix (helix D′), which passes under the
protruding structure to connect with the N terminus of
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Figure 1
Amino acid sequence and secondary structure elements of the dIII
component of human transhydrogenase. Met837 of the complete,
mature enzyme from human heart mitochondria [59] is the N-terminal
methionine of the recombinant dIII protein [5]. Underlined residues are
invariant in ten other published sequences of the dIII region of
transhydrogenase from both animal and bacterial species. The
apparent ‘fingerprint’, Gly-X-Gly-X-X-Ala/Val, is from
residues 889–894. The positions of helices (red rectangles) and
β strands (green arrows) were derived by PROCHECK analysis [60].
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strand β5. At the C terminus of this strand, a long loop
(loop E) passes over the protruding helix D/loop D and
over the bound nucleotide. Another short stretch of 310
helix joins loop E to β6. With the exception of amino acid
residues 859–866 and a few sidechains, there is good non-
crystallographic symmetry between the two monomers in
the asymmetric unit (root mean square deviation [rmsd]
between the two monomers is 0.252 Å calculated using
180 equivalent Cα atoms).
In ten other published amino acid sequences of trans-
hydrogenases, 53 residues out of approximately 205 are
invariant. These conserved residues cluster in several
regions: at the N terminus, where the polypeptide chain
emerges from the last transmembrane helix of dII; in the
turn at the C terminus of β1; in the nicotinamide-binding
turn at the C terminus of β2; in helix B; in helix D/loop D;
and in loop E. These clusters are expected to be impor-
tant for catalysis.
Dinucleotide binding
Of the large number of proteins that utilise NAD(P)(H),
by far the majority bind the nucleotide in a Rossmann fold
[16–18] (exceptions, having ‘non-classical’ binding, are
reviewed in [19]). Two subgroups of Rossmann-fold struc-
tures were identified — LDH-like and glutathione reduc-
tase-like — but both bind NAD(P)(H) in essentially the
same way [19]. Although different combinations of
sidechains are involved in specific contacts, the
nucleotides in the known structures were always observed
to bind at the C-terminal edge of the β sheet, such that
the adenosine lies in a cleft between β1 and β2 and the
pyrophosphate group makes contact with the loop
between β1 and helix A. This loop contains the Gly-X-
Gly-X-X-Gly of the ‘fingerprint region’. More recently,
two variations on the classical theme have been described.
Interaction of NAD(H) and the Rossmann fold of alde-
hyde dehydrogenase is through a ‘β4–αD–β2 motif’ [20];
not unexpectedly, this protein does not have the Gly-X-
Gly-X-X-Gly sequence in the first βαβ unit. Dehydro-
quinate synthase has a five-stranded Rossmann fold,
comprising a βαβ unit followed by a βαβαβ motif [21].
The pyrophosphate group binds across the glycine-rich
first turn in the βαβαβ motif, such that the adenosine
moiety is in a cleft located between its first and second
strands. Transhydrogenase dIII has a more surprising
nucleotide-binding mode. It has a strong resemblance to
the classical LDH-like fold, and has a conserved Gly-X-
Gly-X-X-Ala/Val sequence in the fingerprint region in the
loop between β1 and helix A. It binds NADP+ at the
C-terminal edge of the β sheet but with an approximately
180° reverse orientation; the adenosine moiety is located
predominantly within the second βαβαβ motif and the
nicotinamide mononucleotide (NMN) within the first.
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Figure 2
The overall fold of transhydrogenase dIII.
(a) Stereoview Cα trace with every tenth Cα
atom highlighted. The figure was constructed
using TURBO-FRODO [51]. (b) Ribbon
diagram constructed using MOLSCRIPT [61].
The nucleotide is shown in ball-and-stick
representation; NIC, nicotinamide ring.
Features indicating that the nucleotide-binding
properties of the first and second βαβαβ motifs
have been reversed, relative to the classical
LDH fold, are as follows. Firstly, the cleft for the
adenine ring is between the C termini of β4 and
β5, where helix F turns away from the back of
the sheet. In the classical LDH fold, the cross-
over region, helix C, creates the cleft between
the C termini of β1 and β2. Secondly, the cleft
for the adenosine moiety is enlarged because
β4 terminates before the adjacent strands β1
and β5. In the LDH-like structures, β1 often
terminates before β2 and β4 [18]. Thirdly,
residues binding the 2′-phosphate group of
NADP+ are located in the C-terminal loop of
β5. In classical dehydrogenases that bind
NADP(H), residues binding the 2′-phosphate
are usually located at the C terminus of β2.
Fourthly, the pyrophosphate group of NADP+ is
hydrogen bonded via mainchain amides to the
N-terminal residues of helix D. Helix A is the
‘pyrophosphate-binding helix’ in the classical
Rossmann fold.
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Thus, the adenosine lies in a cleft positioned over the C
termini of strands β4 and β5 and ending where helix E
peels away to the back of the molecule. The pyrophos-
phate group runs across the turn between β4 and helix D,
and the nicotinamide ring is located within the loop
between β2 and helix B. Loop E arches up over the
pyrophosphate group and the ribose of the nicotinamide
to form a ‘lid’ across the bound nucleotide (Figure 2b).
A portion of the electron-density map illustrating the con-
formation of the nucleotide and a selection of important
adjacent residues is shown in Figure 3. As in most
nucleotide-binding proteins [18], the NADP+ is in an
extended conformation (~13.4 Å from adenine N9 to
nicotinamide N1). The adenine ring is in the anti confor-
mation relative to its ribose; the nicotinamide ring is in the
syn conformation.
Specificity of the bound NADP+ and stereochemistry of
hydride transfer
The complex set of interactions between Lys999, Arg1000
and Ser1001, and the 2′-phosphate of the nucleotide
(Figures 4,5), accounts for the pronounced specificity of
the dIII component of transhydrogenase for NADP(H),
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Figure 3
Refined electron-density map of bound
NADP+. SIGMAA-weighted 2mFo–DFc
electron density contoured at 1σ. The diagram
was constructed from the final model at 2.0 Å
resolution using TURBO-FRODO [50].
Figure 4
Hydrogen bond and van der Waals contacts
between NADP+ and dIII. The figure was
constructed on subunit 1 using LIGPLOT
[62]. Mse, selenomethionine; Gol, glycerol.
Hydrogen bonds are shown as dashed green
lines and van der Waals interactions by red
shading; atoms are in standard colours. The
adenine-ring system is in van der Waals
contact with sidechains in the C-terminal
loops of strands β1, β5 and β6. The
nicotinamide ring is bound by amino acid
residues in the C-terminal loop of β2. Apart
from its contact with the bound glycerol
molecule, the NMN ribose is hydrogen
bonded only by Arg925 and Asp967. There
are potentially seven hydrogen bonds
between the protein (Lys999, Arg1000 and
Ser1001) and the 2′-phosphate of the
adenosine ribose. The two negative charges
on the 2′-phosphate are, thus, compensated
by the positive charges on the lysine and
arginine sidechains. The 2′-phosphate is also
hydrogen bonded to a bound water molecule.
In addition to Gly924, from the nicotinamide-
binding loop, there are two sets of residues
which form hydrogen-bond contacts with the
pyrophosphate group: Asn966, Asp967 and
Thr968 from the N terminus of the protruding
helix D; and Tyr890 and Arg925, which form
part of an interacting triad of residues linking
the nicotinamide-binding site with the lid-like
loop E.
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relative to NAD(H) [22,23]. The stability of this region,
reinforced because the C-terminal residue of β5 (Lys999)
is hydrogen bonded to residues in adjacent strands of the
β sheet and to Ser1001, indicates that it might serve as a
fulcrum for conformational changes associated with
switching the NADP(H)-binding affinity as loop E opens
and closes during catalysis (see below). The importance of
these residues in catalysis and nucleotide binding was
demonstrated by site-directed mutagenesis [24]. Substitu-
tion of the Lys999 and Arg1000 equivalents in Escherichia
coli transhydrogenase with cysteine, led to inhibition of
reverse transhydrogenation by 70% and 90%, respectively,
and increased the Km value for NADPH by threefold and
ninefold, respectively.
The nicotinamide ring is bound to the C-terminal loop of
β2, with its proR face effectively shielded from the solvent
by the polypeptide backbone of residues Gly924 to
Met926 (Figure 5). The carbonyl oxygen atoms of Gly924
and Arg925 are both close enough to form an electrostatic
interaction with the ring, and Arg925 Cα is in van der
Waals contact with nicotinamide atoms NC3 and NC7, all
on the proR face. On the proS face the invariant Val922 is
in van der Waals contact with NC2 and NC3 (weaker
contact in monomer 2 than monomer 1), but other ring
atoms, including NC4, are exposed to the solvent. In the
complete enzyme, the nicotinamide ring is brought into
apposition with the dihydronicotinamide ring of NADH on
dI to effect a direct transfer of hydride equivalent between
the two C4 atoms [6,7,25]. It is probable that this mutual
positioning will involve the mainly exposed proS face of
the nicotinamide ring of NADP+ and, therefore, that H–
will be transferred to the B position of its NC4, explaining
the well-known stereochemistry at this site [26].
The fingerprint region and nucleotide binding
The function of the glycine-rich sequence in the first βαβ
region of the classical dinucleotide-binding fold has been
described in detail [17,19,27]. In dIII, however, the Gly-X-
Gly-X-X-Ala/Val sequence (see Figure 1) has adopted a
different function. The first glycine, at position 889, has an
extended conformation that is required for the correct
positioning of Tyr890 at the end of the strand (see below);
it does not make a sharp bend to direct the polypeptide
chain under the bound nucleotide. The importance of this
residue in dIII is signified by the observation that even
conservative substitution of its equivalent in E. coli trans-
hydrogenase gives an inactive protein [28]. The second
glycine (position 891) makes van der Waals contacts with
the adenine ring; it is not required for the approach of the
pyrophosphate, which is ~5.9 Å away. In classical dehydro-
genases that bind NADP(H) as distinct from NAD(H), the
third glycine residue in the fingerprint region is often
replaced by an alanine or a valine, although the functional
significance of this is unclear [29,30]; in dIII, the Cα atom
of Ala894 is > 10 Å from the 2′-phosphate group.
The β4–D–β5 motif in dIII has the equivalent role in
nucleotide binding to the β1–αA–β2 motif of the classical
Rossmann fold. The sequence in the β4–D turn of dIII is
highly conserved in transhydrogenases from different
species, but is only weakly related to the classical finger-
print region. Gly964 has the same function as the first
glycine in a classical fingerprint; it is positioned at a 90°
turn to allow the polypeptide chain to pass under the
pyrophosphate group of the bound nucleotide. Asn966 has
a similar role to the second glycine in the classical finger-
print; it permits approach of the pyrophosphate to the
protein backbone (Figure 5). The residue in the β4–D
turn of dIII that is in the equivalent position to the last
glycine in the fingerprint is not conserved (valine,
isoleucine, or threonine in published sequences) and does
not have an obvious function in nucleotide binding.
A search of the Protein Data Bank (PDB) using the program
CE [31] showed dIII to have a similar fold to that of the
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Figure 5
The NADP+-binding pocket of dIII. Amino acid
residues are shown with atoms in standard
colours: C, yellow; O, red; and N, blue. The
nucleotide is shown in red. NIC, nicotinamide
ring; ADE, adenine ring.
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FAD-binding domain of pyruvate oxidase (POX; Figure 6)
[32,33]. Similarities were also found with sequence-related
domains of enzymes of the same family that do not bind
FAD, specifically, benzoylformate decarboxylase, pyruvate
decarboxylase and transketolase. POX is remarkable in that
it binds FAD with two βαβαβ units. There are several
classes of protein structure that bind FAD [34] but, apart
from POX, only the fold typified by that in glutathione
reductase utilises the βαβαβ motif. There, the ADP moiety
of the FAD binds to a single βαβαβ motif (usually associ-
ated with one or two extra parallel strands with connectivi-
ties to other parts of the protein). Within this single motif
there is a Gly-X-Gly-X-X-Gly fingerprint at the β1–αA
turn, which has the same function in its interaction with
adenosine as that in the classical NAD(P)(H)-binding fold.
Interestingly, POX not only utilises two βαβαβ units to
bind FAD, but, as in dIII, the adenosine is bound to the
second rather than the first of the two units.
In POX there is no Gly-X-Gly-X-X-Gly fingerprint in
either the first or the second βαβαβ unit. It is all the more
remarkable, therefore, that dIII does have the sequence
(in its modified form) in the first (nonpyrophosphate-
binding) motif. The most probable explanation is that dIII
has evolved from an ancestral form that bound nucleotide
in the classical mode. Following a reversal of binding ori-
entation, the fingerprint sequence was retained and indi-
vidual residues adapted to fit new functions (as above).
Less probable is the possibility that glycine residues (or
alanine/valine) have independently arisen at the β1 to
helix A turn in identical positions to those in the Ross-
mann structure, but to suit different functions. The differ-
ence in the sequences indicates that the similarity
between the folds of dIII and POX has arisen by conver-
gent evolution. There is no evidence in POX, however, as
to whether or not an ancestral form of the protein pos-
sessed a fingerprint in its N-terminal βαβαβ unit.
The binding of dIII to dI and dII
In a homology model of dI [35], built on the basis of com-
parisons with the structure of alanine dehydrogenase [36],
the nicotinamide ring of NADH is located at the bottom
of a cleft separating domain dI.1 from domain dI.2. In con-
trast, the nicotinamide ring of NADP+ in dIII is exposed
at one end of a ridge dividing two relatively flat protein
surfaces (Figure 7). It is probable that, in the complete
enzyme, the ridge of dIII is inserted into the putative cleft
of dI to bring the C4 atoms of the two nicotinamide rings
into apposition to permit hydride transfer [6,7,25]. Support
for this positioning was obtained in a recent nuclear mag-
netic resonance (NMR) experiment, in which chemical-
shift changes in the backbone amides of Rhodospirillum
rubrum dIII upon addition of dI were almost completely
confined to the regions that we can now see correspond to
the two, ridge-adjacent surfaces [37]. Only low-affinity
interactions were detected in these experiments; changes
in chemical shift resulting from high-affinity interactions
were obscured by resonance broadening.
The ‘back’ of dIII is covered by the three amphipathic
helices, 0, A and F. The exposed surface of these helices is
highly polar and has few conserved residues. This region
is, therefore, probably also in contact with the solvent in
the complete protein. Taken together with the likely site
of interaction with dI (covering the C-terminal loops of the
β strands and the outer edge of the first βαβαβ motif), this
suggests that the transmembrane dII must interact with
the ‘front’ of dIII, in the region of the protruding helix
D/loop D. In intact transhydrogenase, the N terminus of
dIII is directly connected to dII through the polypeptide
chain, but the segment that emerges from the membrane-
spanning component is disordered in the X-ray structure
(residues 837–858) and according to NMR data [37]. It
comprises mostly small polar amino acid residues, and in
the detergent-solubilised complete enzyme is susceptible
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Figure 6
Superimposition of POX and dIII. The
alignment was established as indicated in the
text. The Cα atoms of dIII (yellow) and POX
(blue) superimpose with an rmsd of 1.06 Å
using 86 pairs of equivalent Cα atoms. There
is no sequence similarity between dIII and
POX, except in the region of strand 4 where
in all available sequences of both proteins
there is a glycine residue (position 964 in
human dIII), which allows for a 90° turn of the
polypeptide chain under the nucleotide
pyrophosphate (see text and [33]), and an
aspartate residue (at the N terminus of the
strand) for which a specific function is not yet
ascribed. There is an analogous conserved
charged residue at the N terminus of strand 1
in the classical dinucleotide-binding proteins,
which has no known function [19]. In contrast
to LDH-like structures, POX does not have a
pyrophosphate-binding α helix; in dIII, the
pyrophosphate-binding helix D also has a
rather loose structure, with its first turn in a
310 configuration.
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to cleavage by proteases [38,39], suggesting that this linker
region is somewhat flexible.
Interactions between bound dinucleotide, helix D/loop D
and loop E
Isolated dIII binds NADP+ and NADPH extremely
tightly [5,8], the Kd (≤ 10–10 M) being some three orders of
magnitude lower than the binding constants of many
soluble dehydrogenases for their nucleotides. It seems
probable that the high affinity of dIII for nucleotides can
be at least partly attributed to loop E, which folds down to
form a lid over the ligand. In the complete transhydroge-
nase, however, the lid must open during the catalytic cycle
to allow rapid exchange of NADP+ and NADPH. Kinetic
studies indicate that there is interconversion between the
‘open’ and ‘occluded’ states of dIII at key steps during
catalysis [7,10]. The disposition of two sets of amino acid
residues, relative to the bound nucleotide, indicates an
involvement in this interconversion.
Tyr890, Arg925 and Tyr1006 lie in an interesting posi-
tion over the pyrophosphate group of the nucleotide
(Figures 5,8). Tyr890 extends from the C terminus of β1.
Tyr1006 is at the apex of loop E, in a β turn supported by
a hydrogen bond between Gly1005 O and Ala1008 N.
Both tyrosine residues are hydrogen bonded to the
nucleotide pyrophosphate (although the interaction with
Tyr1006 is weak). The guanidinium group of Arg925 is
held between, and approximately equidistant from, the
aromatic groups of the two tyrosyl sidechains by its
hydrogen-bond contact with atoms in the ribose and the
pyrophosphate groups of the bound NADP+, by van der
Waals interactions (between the Cα atom of the arginine,
and NC3 and NC7) and by Coulombic repulsion from
the positively charged nicotinamide ring (Figure 5).
Mutagenesis of the E. coli equivalent of Tyr1006 to
phenylalanine resulted in only a 40% decline in the rate
of uncoupled, reverse transhydrogenation, although sub-
stitution with leucine, histidine, asparagine or isoleucine
led to virtually complete inhibition [40]. Evidently, the
aromatic character of this residue is important in cataly-
sis. In contrast to Tyr1006, replacement of the E. coli
equivalent of Tyr890 with a number of different residues
always caused some inhibition, although substantial
activities often remained. Mutagenesis of the E. coli
equivalent of Arg925 has only been studied in dI–dIII
protein complexes, where substitution with cysteine had
only small effects on transhydrogenation [24]; experi-
ments to change this residue in the complete enzyme,
during the coupled reaction, should be revealing.
The invariant Asn966 and Asp967 in helix D are in hydro-
gen-bond contact with residues in the apex of loop E and
with the pyrophosphate group of the nucleotide
(Figures 5,8). In addition, Asp967 makes hydrogen bonds
with two water molecules located between helix D and
loop E. Although it is buried in the protein, Asp967 is not
charge-compensated by an adjacent, basic sidechain. The
equivalent of Asp967 in E. coli transhydrogenase has been
replaced by site-directed mutagenesis. Reverse transhydro-
genation in the complete enzyme was inactivated upon its
substitution with a number of other residues [41], whereas
in dI–dIII complexes the reverse reaction was stimulated,
and ‘cyclic transhydrogenation’ was only partially inhibited
after replacement with cysteine [24]. Given that in dI–dIII
complexes the reverse reaction is profoundly rate-limited
by NADP+ release, and the cyclic reaction does not obliga-
torily involve association/dissociation of NADP+/NADPH
[8,42], this indicates a role for Asp967 in the interconver-
sion between the open and occluded states.
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Figure 7
The nicotinamide ring of NADP+ is exposed
on a ridge of the dIII protein. The invariant
residues Pro927, Val932 and Glu936 lie
along the ridge, on one side of the
nicotinamide ring, with Tyr1006 on the other
side (at the apex of loop E). One surface
adjacent to the ridge is composed of the
strongly conserved hydrophobic residues of
the nicotinamide-binding loop and of helix B,
the turn between helix B and β3, and the
mainly acidic C-terminal residues of helix C.
The other surface is made up of several,
strongly conserved residues involved in
nucleotide binding – notably, Tyr890, Arg925
and Arg1000 and a group of mainly polar
residues in the turn between β1 and 
helix A — and the invariant residues Lys1027
and Lys1028 in the loop between β6 and
helix F. The guanidinium group of Arg925 is
sandwiched between the tyrosyl groups of
Tyr890 and Tyr1006. Protein atoms are in
yellow and nucleotide atoms in red; the C4
atom of the nucleotide is shown in grey.
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It is clear that there is a focus of hydrogen-bond interac-
tions from Tyr890, Arg925 and Tyr1006, and from
Asn966 and Asp967, to the pyrophosphate group of the
NADP+. The expected single negative charge on the
5′-phosphate of the adenosine moiety (AP) is probably
compensated by the positive charge of the guanidinium
group of Arg925. The 5′-phosphate of the NMN moiety
(NP) lies deeper within the core of the protein, however,
and is some distance from any positively charged
sidechain, although it makes hydrogen bonds with
Gly924, Tyr890, Asn966 and Thr968 and a weak contact
with Tyr1006.
Catalytic mechanism
In our binding-change mechanism [10,11,25], the isolated
form of dIII–NADP+ corresponds to an occluded-state
intermediate, which, in forward transhydrogenation, is
poised ready for hydride transfer. In the complete
protein, this intermediate is produced from the open state
of dIII–NADP+ as a result of protonation of dII–dIII from
the p-phase (outside the mitochondrion or bacterium).
Following hydride transfer from dI–NADH, occluded
dIII–NADPH is then returned to the open state as a
result of deprotonation of dII–dIII to the n-phase. To
identify regions of the protein that undergo conforma-
tional changes during reduction of the nucleotide,
changes in the magnetic environment of amide groups in
R. rubrum dIII were monitored when bound NADP+ was
replaced with bound NADPH [37,43]. In Figure 9,
residues, in which the backbone amide chemical shifts
were perturbed by the nucleotide substitution are
mapped on to the human dIII crystal structure. Not unex-
pectedly, in view of their proximity to the binding pocket
of the nicotinamide ring, Gly889 and Tyr890 in the turn
at the C terminus of β1, and residues from Ala923
through Met926, are affected by nucleotide reduction.
Magnetic changes are also detected in a large number of
residues located in helix D/loop D and loop E, but not
elsewhere in the protein. Although changes in chemical
shift cannot yet be precisely interpreted in structural
8 Structure 2000, Vol 8 No 1
Figure 8
Interactions between NADP+, helix D/loop D
and loop E. (a) Residues are shown with
atoms in standard colours: C, yellow; O, red;
and N, blue. (b) Residues in helix D/loop D
are shown in blue and residues in loop E are
in green. The nucleotide is red in both panels.
NIC, nicotinamide ring; ADE, adenine ring.
There are hydrogen-bond contacts between
Asn966/Asp967 in helix D and both the
pyrophosphate group and several residues in
loop E (Gly1003, Tyr1006, Ala1007 and
Asn1011). Other hydrogen-bond and
hydrophobic contacts with helix D occur
C-terminal to this interaction site on loop E.
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terms, a conformational event originating in the nicotin-
amide ring is evidently transmitted from the binding
pocket through the lid and the protruding front
helix–loop. It is suggested that these events result from
loss of positive charge on the nicotinamide ring upon
reduction, which leads to local displacements in the
amino acid triad (Tyr890, Arg925, Tyr1006) and hence to
propagation of the conformational change through loop E,
through helix D/loop D (Figure 9), to the interacting
loops between the transmembrane helices of dII. A con-
formational change in the protein at the hydride transfer
step is crucial to relay the information from the nucleotide
pocket, to the H+-binding/translocation residue(s), that
NADP+ has become reduced, in order to trigger a change
in H+ access from one side of the membrane to the other.
The observed conformational changes might represent
part of this information relay.
The process of occlusion is central in energy coupling by
transhydrogenase. It is required to allow the switch in the
binding affinity of dIII for NADP+ and NADPH to take
place, and to facilitate hydride transfer [10,11,25]. If, as
seems probable, occlusion is a result of the movement of
loop E over the nucleotide, then the important region in
the protein (centred on Asn966 and Asp967 in helix D)
takes on a special significance (Figure 8). In this region
there are numerous contacts with loop E, with the
pyrophosphate and adenosine ribose groups of the bound
ligand, and with the Tyr890, Arg925, Tyr1006 triad, and
hence the nicotinamide-binding loop. It is envisaged that
changes in ionisation/conformation in this region would
lead to changes in the nucleotide-binding pocket that
cause closure of the loop E lid, destabilise the NADP+ rel-
ative to NADPH [25,44], and shift the nicotinamide ring
into apposition with that of NADH on dI to allow hydride
transfer. The fundamental question is how these ionisa-
tion/conformational changes are driven by proton translo-
cation through dII. So far, biochemical experiments have
failed to provide a clear indication as to the nature of the
coupling [45], but two possibilities are consistent with the
crystal structure. Firstly, protons might be conducted from
dII directly into the active centre of dIII around Asn966
and Asp967 to effect the nucleotide-binding change. It is
interesting in this context that Asp967 and the NMN
phosphate are inaccessible to solvent molecules, and both
are involved in complex hydrogen-bond networks. Sec-
ondly, energy might be transmitted mechanically from dII
to dIII via helix D/loop D, in a way that is analogous to
rotation of the γ subunit in the transmission of energy
between F1 and F0 of proton-translocating ATP synthase
[46]; here too, changes in nucleotide-binding affinity are
crucial in the transduction process [9]. The subunit com-
position of transhydrogenase is not compatible with rota-
tional catalysis, but other modes of movement of helix
D/loop D can be considered. Experiments are underway
to distinguish between these possibilities.
Biological implications
Transhydrogenase is found in the inner membranes of
animal mitochondria and the cytoplasmic membranes of
bacteria. It couples the transfer of reducing equivalents
between NAD(H) and NADP(H) to proton transloca-
tion across the membrane. Under most physiological
conditions transhydrogenase serves to drive the reduc-
tion of NADP+ by NADH using the energy of the
proton gradient generated by the respiratory chain. The
NADPH is used in biosynthesis and in glutathione
reduction, but transhydrogenase also has a role in con-
trolling flux through the isocitrate dehydrogenase step in
the tricarboxylic acid cycle. The mechanism by which
transhydrogenase couples its redox reaction to proton
pumping is not understood, although evidence suggests
that a change in the affinity of the protein for NADP+
and NADPH is central to energy transduction.
We describe here the first high-resolution structure of
the recombinant, NADP(H)-binding component (dIII)
of human heart transhydrogenase. The protein has the
‘classical’ Rossmann fold found in lactate dehydroge-
nase. It is a six-stranded β sheet flanked by helices. Its
NADP+, however, is bound the ‘wrong way round’: the
adenosine moiety is located in the second βαβαβ motif,
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Figure 9
Conformational changes in dIII upon exchanging NADP+ for NADPH.
Amino acid residues from R. rubrum dIII for which backbone amide 15N
or 1HN chemical shifts were significantly perturbed upon replacing
bound NADP+ with NADPH [37] are mapped in green on to a space-
filling model of the crystal structure of human dIII. Other protein atoms
are in yellow and the nucleotide atoms are in red. The protruding helix
D/loop D is shown at the bottom of the illustration. The figure was
generated using TURBO-FRODO [50].
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and the nicotinamide mononucleotide moiety in the first.
The nicotinamide ring is exposed on a ridge of the
protein, where, in the complete enzyme, it must
approach the nicotinamide ring of NADH (on the dI
component) to permit direct transfer of reducing equiva-
lents. One interesting feature of dIII is helix D/loop D,
which protrudes perpendicularly from the β sheet; this
region probably interacts with the membrane-spanning
dII component. A second interesting feature is loop E,
which forms a ‘lid’ over the bound NADP+. There are
numerous hydrogen-bond contacts between helix D/loop
D, loop E and the pyrophosphate group of the
nucleotide. Ionisation and conformational changes
resulting from proton translocation through dII are evi-
dently transmitted through helix D/loop D, causing
opening and closing of the loop E lid and driving the
switch in NADP(H)-binding affinity that is necessary
for energy coupling.
Materials and methods
Protein preparation and crystallisation
The native dIII component of human heart transhydrogenase was
cloned from cDNA, expressed in E. coli and purified, as described [5].
Crystals were grown using hanging-drop vapour diffusion (SJ Peake, JB
Jackson and SA White, unpublished data). To obtain the selenomethionyl
(SeMet) derivative of dIII the methionine auxotroph E. coli B834 (DE3)
was transformed with pSJP2 [5] and cells grown in M9 minimal
medium supplemented with SeMet and induced with 1.0 mM isopropyl-
β-D-thiogalactoside, as described [47]. The protein was purified and
crystals were grown as for the native protein. The human dIII protein
crystallises in the space group P4122 with cell dimensions
a = b = 58.1 Å, c = 250.8 Å. There are two monomers in the asymmet-
ric unit giving a calculated Vm of 2.3 Å3 Da–1.
Data collection and processing
Diffraction data were collected at beamline ID14-4 of the European
Synchrotron Radiation Facility (ESRF), Grenoble, using a Quantum 4
CCD detector system (ADSC, San Diego). Crystals were flash-cooled
to 100K in the cryostream immediately prior to data collection. Three
data sets were collected to 2.5 Å resolution from one SeMet crystal at
wavelengths λ1 = 0.9792 Å, λ2 = 0.9794 Å and λ3 = 0.9315 Å (corre-
sponding to the inflection point, peak and remote wavelengths of the
selenium K-edge, respectively). Initially, a 55º wedge of data was col-
lected at each wavelength, followed by a second of 40º. Each diffrac-
tion image was a 1.0º oscillation with 1 s exposure. The time taken to
collect the entire three-wavelength data set was 62 min. Data from a
second crystal were collected to 1.9 Å (λ = 0.9315 Å) in two passes,
covering low and higher resolutions. Data statistics are summarised in
Table 1 (also see Supplementary material).
MAD phasing and model building
The structure of dIII was initially determined to 2.5 Å resolution by the
multiwavelength anomalous dispersion (MAD) technique. SOLVE [48]
was used to locate 14 out of a possible 18 selenium positions. The
map was improved slightly by solvent flattening and histogram match-
ing as incorporated in DM [49]. Secondary structure elements and
clear protein–solvent boundaries were easily discerned in the map. 
A polyalanine chain was fitted using the molecular graphics package
TURBO-FRODO [50]. A total of 168 amino acid residues was built into
one subunit. There was weak density at the N and C termini, but this
could not be fitted with confidence. The selenium positions were used
to help register the amino acid sequence to the polyalanine chain.
Once sidechains were fitted in the first monomer, the model was
rotated and translated to position the second monomer into density,
using the selenium positions as a guide. NADP+ was placed into the
strong electron density at the C-terminal edge of the β sheet in each
subunit. There was no ambiguity in the orientation of the NADP+ mole-
cule in either subunit, because of the strong electron density of the
2′-phosphate group branching off from the adenosine ribose.
Refinement
One round of simulated annealing refinement with noncrystallographic
symmetry restraints was performed [51] against a maximum-likelihood
target incorporating the observed MAD phases from SOLVE. Clear
density at the N and C termini enabled the chain to be extended by
seven and six amino acids, respectively, in both subunits. In addition, a
frame-shift of +1 amino acids was identified in loops C and D. The
model was further refined at 2.5 Å resolution using a combination of
simulated annealing and Powell minimization, interspersed with manual
adjustment of the model, using 2mFo–DFc and mFo–DFc electron-
density maps (SIGMAA-weighted [52]), and a series of simulated
annealing omit maps [53]. The real-space correlation coefficient [54],
calculated for each residue, was used to indicate problems in the
structure that required attention. Noncrystallographic symmetry
restraints were relaxed and then removed as differences between the
two monomers, particularly at the N terminus, became apparent. A
bulk-solvent correction was applied throughout to data from ∞ to 6 Å.
Constant-temperature annealing, using torsion dynamics, was found to
be particularly useful in refining the model [55]. When refinement was
essentially complete to 2.5 Å, high-resolution data were incorporated,
stepwise, until a complete 2.0 Å resolution data set was included. After
further refinement, individual B factors were refined and solvent mole-
cules were built in. Electron density for residues 837–858 could not be
found in either monomer, clearly indicating disorder at the N terminus.
The final model has 3004 nonhydrogen atoms, including 80 water mol-
ecules and two glycerol molecules. The crystallographic R factor is
23.7% with an R free of 25.8% (calculated with 5% of the data
excluded from refinement). The model (364 amino acid residues,
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Table 1
Data collection and phasing statistics.
Crystal 1 Crystal 2
Data set λ1 (0.9792 Å) λ2 (0.9794 Å) λ3 (0.9315 Å) (0.9315 Å)
dmin (Å) 39–2.5 39–2.5 39–2.5 17–1.9
Completeness (%) 99.9 99.9 100.0 99.3
Redundancy 6.5 6.5 7.0 3.8
No. of unique reflections 14,953 15,865 15,402 35,120
I/σI* 6.6 (4.7) 6.6 (4.7) 6.7 (3.9) 4.2 (0.9)
Rsym (%)† 7.0 6.7 6.6 10.7
*Values given for I/σI are for all data. Values in parentheses are for data in the highest resolution shell. †Rsym = Σj|<I>–Ij|/Σ<I>, where Ij is the
intensity of the jth reflection and <I> is the average intensity.
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80 water molecules, two glycerol molecules and two sulphate ions) has
good geometry with rmsd values for bonds and angles of 0.01 Å and
1.421º, respectively [56]. Model statistics are summarised in Table 2.
Accession numbers
The coordinates have been deposited into the Protein Data Bank
(accession number 1DJL).
Supplementary material
Supplementary material including MAD analysis and phasing statistics
is available at http://current-biology.com/supmat/supmatin.htm.
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Table 2
Refinement statistics.
Resolution (Å) ∞–2.0
Reflections (N) 30,238
R factor (%)* 23.7
Rfree (%)† 25.8
Rms deviation‡
bond lengths (Å) 0.010
bond angles (°) 1.42
Average B value (Å2)
monomer 1 35.27
monomer 2 36.03
Rms deviation between monomers (Å)§ 0.252
No. nonhydrogen atoms in final model 3004
*R factor = ΣhklFo–Fc/ΣhklFo. †Rfree is the crystallographic R
value calculated using 5% of the native data withheld from refinement.
‡Root mean square (rms) bond lengths and bond angles are the rms
deviations from ideal pairs for bond lengths and angles, respectively.
The data were indexed and integrated using Mosflm 6.0 [57]. Data
were scaled and manipulated using the CCP4 suite of programs [58].
§Calculated for 180 equivalent Cα atoms.
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